Background illustration for clinical trials search

Paid Clinical Trials Washington, D.C.

Discover 775 paid clinical trials in Washington, D.C.. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Improving Genetic Counseling for BRCA+ Mothers

for
Breast Cancer
Location: Washington DC
Sponsor: Georgetown University

Sex: Female

Age: 18+

Code: NCT04258280

Recruiting

LOTUS-CC: An Observational Research Study to Uncover Subtypes of Cancer Cachexia

for
Advanced Colorectal Carcinoma,
Location: Washington D.C. DC, Winchester VA, Elkton MD, Newark DE,
Sponsor: University of Rochester

Sex: All

Age: 18+

Code: NCT06073431

Recruiting

NCI SBIR Contract for Patient Navigation Tool Prototype Development

for
Pancreas Cancer, Hepatobiliary Cancer, Patient Engagement
Location: Washington DC
Sponsor: GMG Arcdata LLC

Sex: All

Age: 18+

Code: NCT04892927

Recruiting

Hinge vs CCK Implants

for
Revision Arthroplasty, Knee
Location: Washington D.C. DC, Olney MD
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT07818343

Recruiting

Hard Cervical Collar Use Following Posterior Cervical Fusion

for
Spinal Stenosis Cervical, Radiculopathy, Cervical Region,
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 18+

Code: NCT07789288

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Early Signals of the Transition From Immune Quiescence to Activation in the Liver Allograft Microenvironment and in the Circulation

for
Liver Transplant
Location: Washington D.C. DC, Pittsburgh PA, New York NY,
Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 3 - 13

Code: NCT07549503

Phase 2, Recruiting

Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia

for
B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative,
Location: Washington D.C. DC, Newark DE, Richmond VA,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18+

Code: NCT03739814

Phase 2, Recruiting

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

for
Large B-cell Lymphoma, Lymphoma, B-Cell,
Location: Washington D.C. DC, Richmond VA, Norfolk VA,
Sponsor: Lyell Immunopharma, Inc.

Sex: All

Age: 18+

Code: NCT07188558

Phase 3, Recruiting

Comparing Collared and Collarless Femoral Stems in Primary Total Hip Arthroplasty

for
Primary Total Hip Arthroplasty
Location: Washington D.C. DC
Sponsor: Medstar Health Research Institute

Sex: All

Age: 18 - 70+

Code: NCT07337642

Recruiting

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

for
Secondary Progressive Multiple Sclerosis (SPMS)
Location: Washington D.C. DC, Bethesda MD, Frederick MD,
Sponsor: Novartis Pharmaceuticals

Sex: All

Age: 18 - 65

Code: NCT07225504

Phase 3, Recruiting

RESvEraTrol in Parkinson's Disease (RESET)

for
Parkinson's Disease
Location: Washington D.C. DC
Sponsor: Georgetown University

Sex: All

Age: 55 - 70+

Code: NCT07592767

Phase 2, Recruiting

ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Trastuzumab

for
Anatomic Stage I Breast Cancer AJCC v8,
Location: Washington D.C. DC, Bethesda MD, Clinton MD, Olney MD,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: All

Age: 18+

Code: NCT06876714

Phase 3, Recruiting

Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

for
Castration-Sensitive Prostate Carcinoma,
Location: Washington D.C. DC, Fredericksburg VA, Tappahannock VA,
Sponsor: Alliance for Clinical Trials in Oncology

Sex: Male

Age: 18+

Code: NCT06931340

Phase 3, Recruiting

A Study to Evaluate the Safety and Efficacy of Tacabrutideg (BGB-16673) Compared to Pirtobrutinib in Adults With Relapsed/Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

for
Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma
Location: Washington D.C. DC, Newark DE, Philadelphia PA,
Sponsor: BeOne Medicines

Sex: All

Age: 18+

Code: NCT06973187

Phase 3, Recruiting

A Study of INCB123667 in Participants With Platinum-Resistant Ovarian Cancer With Cyclin E1 Overexpression

for
Ovarian Cancer
Location: Washington D.C. DC, Fairfax VA, Baltimore MD,
Sponsor: Incyte Corporation

Sex: Female

Age: 18 - 70+

Code: NCT07023627

Phase 2, Recruiting

A Study of Pirtobrutinib in Participants With Immune Thrombocytopenia

for
Immune Thrombocytopenia (ITP)
Location: Washington D.C. DC, Rochester MN, New Orleans LA,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT06721013

Phase 1, Phase 2, Recruiting

Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers

for
Pancreatic Neoplasm
Location: Washington D.C. DC, Alexandria VA, Fairfax VA,
Sponsor: ECOG-ACRIN Cancer Research Group

Sex: All

Age: 50 - 70+

Code: NCT04239573

Recruiting

Phase 3 Study of Taletrectinib vs Placebo as an Adjuvant Therapy in ROS1 Positive NSCLC (TRUST-IV)

for
Non-small Cell Lung Cancer (NSCLC)
Location: Washington D.C. DC, Fairfax VA, New York NY, Toronto,
Sponsor: Nuvation Bio Inc.

Sex: All

Age: 18+

Code: NCT07154706

Phase 3, Recruiting

EVERO Drug-coated Balloon (DCB) Randomized Trial

for
Peripheral Vascular Disease, Peripheral Arterial Disease
Location: Washington D.C. DC, Camden NJ, New Haven CT,
Sponsor: Cook Research Incorporated

Sex: All

Age: 18+

Code: NCT07144150

Recruiting

A Study to Compare Blinatumomab Alone to Blinatumomab With Nivolumab in Patients Diagnosed With First Relapse B-Cell Acute Lymphoblastic Leukemia (B-ALL)

for
Down Syndrome, Recurrent B Acute Lymphoblastic Leukemia
Location: Washington D.C. DC, Falls Church VA, Baltimore MD,
Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 1 - 30

Code: NCT04546399

Phase 2, Recruiting